Cobalt-Catalyzed Tandem Transformation of 2-Aminobenzonitriles to Quinazolinones Using Hydration and Dehydrogenative Coupling Strategy
摘要:
A tandem synthesis of quinazolinones from 2-aminobenzonitriles is demonstrated here by using an aliphatic alcohol-water system. For this transformation, a cheap and easily available cobalt salt and P(CH2CH2PPh2)(3)(PP3) ligand were employed. The substrate scope, scalability, and synthesis of natural products exhibited the vitality of this protocol.
Substituted quinazolinones as angiotensin II antagonists
申请人:MERCK & CO. INC.
公开号:EP0411766A1
公开(公告)日:1991-02-06
Novel substituted quinazolinones of the formula (I), which are useful as angiotension II antagonists, are disclosed.
本研究公开了可用作血管紧张素 II 拮抗剂的式 (I) 的新型取代喹唑啉酮。
Angiotensin II antagonists incorporating a substituted thiophene or furan
申请人:MERCK & CO. INC.
公开号:EP0510812A1
公开(公告)日:1992-10-28
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl thiophene or phenyl furan derivative of the Formula I are useful as angiotensin II antagonists.
通过亚甲基桥连接到式 I 的新型取代苯基噻吩或苯基呋喃衍生物上的取代杂环可用作血管紧张素 II 拮抗剂。
Angiotensin II antagonists incorporating a substituted benzyl element
申请人:MERCK & CO. INC.
公开号:EP0512676A1
公开(公告)日:1992-11-11
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists.
通过亚甲基桥连接到式 I 的新型取代苯基衍生物的取代杂环可用作血管紧张素 II 拮抗剂。
Angiotensin II antagonists incorporating a substituted indole or dihydroindole
申请人:MERCK & CO. INC.
公开号:EP0517357A1
公开(公告)日:1992-12-09
Substituted heterocycles attached through a methylene bridge to novel substituted indole or dihydroindole derivative of the Formula I are useful as angiotensin II antagonists.
通过亚甲基桥连接到式 I 的新型取代吲哚或二氢吲哚衍生物上的取代杂环可用作血管紧张素 II 拮抗剂。
Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists
申请人:MERCK & CO. INC.
公开号:EP0512870A1
公开(公告)日:1992-11-11
Novel substituted quinazolinones of the formula (I) are useful as angiotensin II antagonists.